Last 7 days
-4.0%
Last 30 days
13.3%
Last 90 days
35.6%
Trailing 12 Months
-28.5%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 171.9B | 43.7B | -4.52% | -15.68% | 24.79 | 3.94 | 1.34% | -1.95% |
IDXX | 40.2B | 3.4B | 1.94% | -10.16% | 59.26 | 11.95 | 4.73% | -8.83% |
CERN | 27.9B | - | 0.98% | 20.75% | 47.36 | 4.81 | - | - |
VEEV | 27.3B | 2.1B | 2.66% | -11.21% | 68.85 | 13.14 | 17.88% | -8.53% |
MID-CAP | ||||||||
CHNG | 9.0B | 3.5B | 11.88% | 31.28% | -116.8 | 2.57 | 7.15% | -34.72% |
INSP | 7.2B | 407.9M | -5.66% | 0.14% | -160.52 | 17.66 | 74.75% | -6.75% |
LNTH | 5.6B | 935.1M | 39.79% | 59.89% | 199.63 | 5.99 | 119.91% | 139.38% |
TDOC | 4.1B | 2.4B | -14.85% | -63.89% | -0.3 | 1.7 | 18.41% | -3085.58% |
QDEL | 3.7B | - | -3.05% | -21.16% | 3.27 | 1.42 | - | - |
OMCL | 2.5B | 1.3B | 3.33% | -58.26% | 435.11 | 1.9 | 14.48% | -92.74% |
SMALL-CAP | ||||||||
SDGR | 1.6B | 181.0M | 13.34% | -28.48% | -10.65 | 8.78 | 31.19% | -48.60% |
TRHC | 135.4M | 357.1M | -14.68% | -11.66% | -0.97 | 0.38 | 33.22% | -57.66% |
ICAD | 32.3M | 29.3M | -52.94% | -68.00% | -2.2 | 1.1 | -19.35% | -69.01% |
HTGM | 3.1M | 6.8M | -1.47% | 116.13% | -0.14 | 0.45 | -21.00% | -36.01% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 6.3% | 180,955,000 | 170,282,000 | 163,152,000 | 154,467,000 | 137,931,000 |
Gross Profit | 13.9% | 101,022,000 | 88,679,000 | 82,593,000 | 77,439,000 | 65,620,000 |
Operating Expenses | 8.0% | 247,839,000 | 229,473,000 | 211,898,000 | 193,613,000 | 177,063,000 |
S&GA Expenses | 12.5% | 30,642,000 | 27,235,000 | 25,630,000 | 23,582,000 | 22,150,000 |
R&D Expenses | 8.0% | 126,372,000 | 116,975,000 | 107,309,000 | 97,278,000 | 90,904,000 |
EBITDA | 2.4% | -144,782,000 | -148,369,000 | -144,248,000 | -131,909,000 | -97,961,000 |
EBITDA Margin | 8.2% | -0.80 | -0.87 | -0.88 | -0.85 | -0.71 |
Earnings Before Taxes | 2.0% | -149,126,000 | -152,223,000 | -147,576,000 | -134,838,000 | -100,808,000 |
EBT Margin | 7.8% | -0.82 | -0.89 | -0.90 | -0.87 | -0.73 |
Net Income | 2.3% | -149,186,000 | -152,691,000 | -147,845,000 | -135,141,000 | -100,393,000 |
Net Income Margin | 8.1% | -0.82 | -0.90 | -0.91 | -0.87 | -0.73 |
Free Cahsflow | -4.6% | -127,697,000 | -122,104,000 | -102,164,000 | -107,820,000 | -77,836,000 |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 4.0% | 689 | 662 | 688 | 720 | 756 |
Current Assets | 1.9% | 534 | 524 | 557 | 586 | 625 |
Cash Equivalents | -12.0% | 90.00 | 103 | 127 | 117 | 120 |
Net PPE | 3.6% | 14.00 | 14.00 | 12.00 | 11.00 | 10.00 |
Goodwill | 0% | 5.00 | 5.00 | 5.00 | 5.00 | - |
Liabilities | 21.0% | 241 | 199 | 195 | 189 | 199 |
Current Liabilities | 22.5% | 109 | 89.00 | 86.00 | 86.00 | 91.00 |
Shareholder's Equity | -3.3% | 448 | 463 | 493 | 531 | 557 |
Retained Earnings | -7.7% | -379 | -351 | -312 | -264 | -229 |
Additional Paid-In Capital | 1.3% | 829 | 818 | 808 | 797 | 787 |
Accumulated Depreciation | - | 12.00 | - | - | - | - |
Shares Outstanding | -12.7% | 62.00 | 71.00 | 62.00 | 62.00 | 62.00 |
Minority Interest | -8.3% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -4.5% | -119 | -114 | -94.75 | -99.47 | -70.67 |
Share Based Compensation | 7.5% | 40.00 | 37.00 | 35.00 | 31.00 | 26.00 |
Cashflow From Investing | 59.7% | 90.00 | 56.00 | 101 | 81.00 | -16.81 |
Cashflow From Financing | -25.8% | 2.00 | 3.00 | 4.00 | 5.00 | 8.00 |
97.0%
82.3%
81.7%
Y-axis is the maximum loss one would have experienced if Schrodinger was unfortunately bought at previous high price.
-14.8%
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | BAILLIE GIFFORD & CO | added | 54.16 | 4,528,520 | 34,050,500 | 0.04% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 83.00 | 1,000 | 3,000 | -% |
2023-02-28 | Voya Investment Management LLC | unchanged | - | -130,762 | 387,238 | -% |
2023-02-24 | NATIXIS | reduced | -5.72 | -459,318 | 994,682 | 0.01% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | -100 | -50,000 | - | -% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | unchanged | - | -65.00 | 935 | -% |
2023-02-16 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | unchanged | - | -21,585 | 65,415 | -% |
2023-02-15 | Metropolitan Life Insurance Co/NY | unchanged | - | -20,071 | 60,929 | -% |
2023-02-15 | Capital Impact Advisors, LLC | added | 74.1 | 115,733 | 279,733 | 0.27% |
2023-02-15 | JANE STREET GROUP, LLC | reduced | -69.23 | -1,537,980 | 460,017 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 8.25% | 5,120,349 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 6.4% | 3,956,805 | SC 13G | |
Feb 09, 2022 | blackrock inc. | 5.0% | 3,057,148 | SC 13G/A | |
Feb 04, 2022 | blackrock inc. | 5.1% | 3,123,673 | SC 13G | |
Dec 01, 2021 | shaw david e | 3.9% | 2,401,777 | SC 13G/A | |
Apr 26, 2021 | shaw david e | 17.2% | 9,662,606 | SC 13G/A | |
Feb 12, 2021 | bill & melinda gates foundation trust | 23.2% | 16,145,857 | SC 13G | |
Feb 10, 2021 | vanguard group inc | 6.76% | 3,805,264 | SC 13G | |
Jan 19, 2021 | shaw david e | 17.2% | 9,662,606 | SC 13G | |
Feb 10, 2020 | flynn james e | 0.52% | 250,000 | SC 13G |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 2.11 -91.75% | 2.58 -89.91% | 3.81 -85.10% | 5.52 -78.41% | 7.36 -71.22% |
Current Inflation | 2.07 -91.90% | 2.50 -90.22% | 3.57 -86.04% | 5.05 -80.25% | 6.64 -74.03% |
Very High Inflation | 2.03 -92.06% | 2.40 -90.61% | 3.29 -87.13% | 4.50 -82.40% | 5.79 -77.36% |
Date Filed | Form Type | Document | |
---|---|---|---|
Feb 28, 2023 | 8-K | Current Report | |
Feb 28, 2023 | 10-K | Annual Report | |
Feb 10, 2023 | SC 13G | Major Ownership Report | |
Feb 10, 2023 | 4 | Insider Trading | |
Feb 10, 2023 | 4 | Insider Trading | |
Feb 10, 2023 | 4 | Insider Trading | |
Feb 10, 2023 | 4 | Insider Trading | |
Feb 10, 2023 | 4 | Insider Trading | |
Feb 10, 2023 | 4 | Insider Trading | |
Feb 10, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-02-09 | Abel Robert Lorne | acquired | - | - | 10,545 | see remarks |
2023-02-09 | Lorton Kenneth Patrick | acquired | - | - | 8,170 | evp & chief technology officer |
2023-02-09 | Herman Jenny | acquired | - | - | 8,000 | svp & controller |
2023-02-09 | Tran Yvonne | acquired | - | - | 7,590 | evp & chief legal officer |
2023-02-02 | Tran Yvonne | acquired | 74,990 | 2.99961 | 25,000 | evp & chief legal officer |
2023-02-02 | Tran Yvonne | sold | -681,380 | 27.2552 | -25,000 | evp & chief legal officer |
2023-01-04 | Farid Ramy | sold | -1,222,670 | 18.2799 | -66,886 | president & ceo |
2023-01-04 | Farid Ramy | acquired | 80,263 | 1.2 | 66,886 | president & ceo |
2022-08-11 | Thornberry Nancy | acquired | 57,024 | 11.52 | 4,950 | - |
2022-08-11 | Thornberry Nancy | sold | -173,250 | 35.00 | -4,950 | - |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues: | |||
Total revenues | $ 180,955 | $ 137,931 | $ 108,095 |
Cost of revenues: | |||
Total cost of revenues | 79,933 | 72,311 | 44,623 |
Gross profit | 101,022 | 65,620 | 63,472 |
Operating expenses: | |||
Research and development | 126,372 | 90,904 | 64,695 |
Sales and marketing | 30,642 | 22,150 | 17,795 |
General and administrative | 90,825 | 64,009 | 41,898 |
Total operating expenses | 247,839 | 177,063 | 124,388 |
Loss from operations | (146,817) | (111,443) | (60,916) |
Other income (expense): | |||
Gain (loss) on equity investments | 11,825 | (1,781) | 4,108 |
Change in fair value | (18,084) | 11,359 | 28,263 |
Other income | 3,950 | 1,057 | 2,253 |
Total other (expense) income | (2,309) | 10,635 | 34,624 |
Loss before income taxes | (149,126) | (100,808) | (26,292) |
Income tax expense | 63 | 411 | 345 |
Consolidated net loss | (149,189) | (101,219) | (26,637) |
Net loss attributable to noncontrolling interest | (3) | (826) | (2,174) |
Net loss attributable to Schrödinger common and limited common stockholders | $ (149,186) | $ (100,393) | $ (24,463) |
Net loss per share attributable to Schrödinger common and limited common stockholders, basic (in usd per share) | $ (2.10) | $ (1.42) | $ (0.41) |
Net loss per share attributable to Schrödinger common and limited common stockholders, diluted (in usd per share) | $ (2.10) | $ (1.42) | $ (0.41) |
Weighted average shares used to compute net loss per share attributable to Schrödinger common and limited common stockholders, basic (in shares) | 71,173,419 | 70,594,950 | 60,024,658 |
Weighted average shares used to compute net loss per share attributable to Schrödinger common and limited common stockholders, diluted (in shares) | 71,173,419 | 70,594,950 | 60,024,658 |
Software products and services | |||
Revenues: | |||
Total revenues | $ 135,578 | $ 113,236 | $ 92,530 |
Cost of revenues: | |||
Total cost of revenues | 29,576 | 26,495 | 18,003 |
Drug discovery | |||
Revenues: | |||
Total revenues | 45,377 | 24,695 | 15,565 |
Cost of revenues: | |||
Total cost of revenues | $ 50,357 | $ 45,816 | $ 26,620 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 90,474 | $ 120,267 |
Restricted cash | 5,243 | 3,000 |
Marketable securities | 360,613 | 456,212 |
Accounts receivable, net of allowance for doubtful accounts of $125 and $108 | 55,953 | 31,744 |
Unbilled and other receivables, net for allowance for unbilled receivables of $100 and $30 | 13,137 | 8,807 |
Prepaid expenses | 8,569 | 5,030 |
Total current assets | 533,989 | 625,060 |
Property and equipment, net | 14,244 | 10,025 |
Equity investments | 25,683 | 43,167 |
Goodwill | 4,791 | 0 |
Intangible assets, net | 587 | 0 |
Right of use assets | 105,982 | 75,384 |
Other assets | 3,311 | 2,851 |
Total assets | 688,587 | 756,487 |
Current liabilities: | ||
Accounts payable | 9,470 | 8,079 |
Accrued payroll, taxes, and benefits | 24,882 | 18,405 |
Deferred revenue | 57,931 | 55,368 |
Lease liabilities | 11,006 | 2,042 |
Other accrued liabilities | 5,510 | 7,317 |
Total current liabilities | 108,799 | 91,211 |
Deferred revenue, long-term | 25,598 | 30,064 |
Lease liabilities, long-term | 105,485 | 77,827 |
Other liabilities, long-term | 800 | 300 |
Total liabilities | 240,682 | 199,402 |
Commitments and contingencies (Note 7) | ||
Stockholders’ equity: | ||
Preferred stock, $0.01 par value. Authorized 10,000,000 shares; zero shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively | 0 | 0 |
Additional paid-in capital | 828,700 | 786,964 |
Accumulated deficit | (379,138) | (229,952) |
Accumulated other comprehensive loss | (2,382) | (651) |
Total stockholders’ equity of Schrödinger stockholders | 447,894 | 557,071 |
Noncontrolling interest | 11 | 14 |
Total stockholders’ equity | 447,905 | 557,085 |
Total liabilities and stockholders’ equity | 688,587 | 756,487 |
Common Stock | ||
Stockholders’ equity: | ||
Common stock | 622 | 618 |
Limited common stock | ||
Stockholders’ equity: | ||
Common stock | $ 92 | $ 92 |